PMV Pharmaceuticals (PMVP) Short Interest Ratio & Short Volume $1.66 -0.04 (-2.07%) (As of 11:19 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PMV Pharmaceuticals Short Interest DataPMV Pharmaceuticals (PMVP) has a short interest of 846,900 shares, representing 1.94% of the float (the number of shares available for trading by the public). This marks a -0.04% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.3, indicating that it would take 4.3 days of the average trading volume of 392,610 shares to cover all short positions.Current Short Interest846,900 sharesPrevious Short Interest847,200 sharesChange Vs. Previous Month-0.04%Dollar Volume Sold Short$1.36 millionShort Interest Ratio4.3 Days to CoverLast Record DateNovember 15, 2024Outstanding Shares51,750,000 sharesFloat Size43,730,000 sharesShort Percent of Float1.94%Today's Trading Volume46,619 sharesAverage Trading Volume392,610 sharesToday's Volume Vs. Average12% Short Selling PMV Pharmaceuticals? Sign up to receive the latest short interest report for PMV Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPMVP Short Interest Over TimePMVP Days to Cover Over TimePMVP Percentage of Float Shorted Over Time Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! PMV Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/2024846,900 shares $1.36 million 0.0%1.9%4.3 $1.61 10/31/2024847,200 shares $1.38 million -13.2%1.9%4 $1.63 10/15/2024975,900 shares $1.45 million -6.2%2.2%4.5 $1.49 9/30/20241,040,000 shares $1.55 million -1.9%2.4%4.8 $1.49 9/15/20241,060,000 shares $1.60 million +1.0%2.4%3.2 $1.51 8/31/20241,050,000 shares $1.65 million -3.7%2.4%2.9 $1.57 Get the Latest News and Ratings for PMVP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PMV Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/15/20241,090,000 shares $1.68 million +1.9%2.5%2.8 $1.54 7/31/20241,070,000 shares $1.78 million -7.8%2.5%2.5 $1.66 7/15/20241,160,000 shares $1.89 million -48.2%2.7%2.4 $1.63 6/30/20242,240,000 shares $3.63 million -11.5%5.1%4.2 $1.62 6/15/20242,530,000 shares $4.23 million -0.8%5.8%5.2 $1.67 5/31/20242,550,000 shares $4.64 million -0.8%5.9%4.6 $1.82 5/15/20242,570,000 shares $5.55 million -8.9%6.3%4.6 $2.16 4/30/20242,820,000 shares $5.08 million +1.4%6.9%4.7 $1.80 4/15/20242,780,000 shares $4.55 million +6.9%6.8%4.8 $1.64 3/31/20242,600,000 shares $4.42 million +15.0%6.4%4.7 $1.70 3/15/20242,260,000 shares $3.98 million +14.1%5.6%4.1 $1.76 2/29/20241,980,000 shares $3.66 million +7.6%4.9%4 $1.85 2/15/20241,840,000 shares $2.82 million +5.1%4.6%4 $1.53 1/31/20241,750,000 shares $3.08 million +12.9%4.8%3.8 $1.76 1/15/20241,550,000 shares $3.49 million -4.3%4.2%2.8 $2.25 12/31/20231,620,000 shares $5.02 million -13.4%4.4%2 $3.10 12/15/20231,870,000 shares $4.21 million +4.5%5.0%2.3 $2.25 11/30/20231,790,000 shares $4.10 million +12.6%4.9%2.2 $2.29 11/15/20231,590,000 shares $3.83 million -16.3%4.4%2 $2.41 10/31/20231,900,000 shares $2.87 million -66.8%5.5%2.4 $1.51 10/15/20235,720,000 shares $11.44 million -9.5%16.6%8.1 $2.00 9/30/20236,320,000 shares $38.80 million -0.6%18.3%14.9 $6.14 9/15/20236,360,000 shares $42.68 million +15.4%18.4%14.3 $6.71 8/31/20235,510,000 shares $39.78 million +0.6%16.3%13.9 $7.22 8/15/20235,480,000 shares $42.63 million -16.8%16.3%13.6 $7.78 7/31/20236,590,000 shares $43.10 million -2.2%20.7%19.2 $6.54 7/15/20236,740,000 shares $43.61 million -0.6%21.1%20.4 $6.47 6/30/20236,780,000 shares $42.44 million +2.7%21.3%19.5 $6.26 6/15/20236,600,000 shares $41.38 million +0.6%20.7%17.3 $6.27 5/31/20236,560,000 shares $35.10 million +0.5%20.6%12.2 $5.35 5/15/20236,530,000 shares $37.74 million -7.0%20.5%10.8 $5.78 4/30/20237,020,000 shares $32.36 million +1.5%22.6%11 $4.61 4/15/20236,920,000 shares $30.38 million -5.6%22.3%10.3 $4.39 3/31/20237,330,000 shares $34.96 million -12.0%23.7%10.5 $4.773 Dirt-Cheap Stocks You Can’t Afford to Ignore (Ad)Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.Get your FREE look at these THREE companies right here. 3/15/20238,330,000 shares $46.23 million -1.2%26.9%13.2 $5.55 2/28/20238,430,000 shares $60.78 million +0.5%27.2%15.7 $7.21 2/15/20238,390,000 shares $63.09 million -6.2%27.1%16.4 $7.52 1/31/20238,940,000 shares $73.31 million -4.4%28.8%16.5 $8.20 1/15/20239,350,000 shares $77.04 million -1.5%30.1%17.1 $8.24 12/30/20229,490,000 shares $82.56 million +1.9%30.6%17.6 $8.70 12/15/20229,310,000 shares $88.82 million -5.6%30.0%16.7 $9.54 11/30/20229,860,000 shares $98.40 million -5.7%31.8%16.2 $9.98 11/15/202210,460,000 shares $118.51 million -9.4%33.7%16.8 $11.33 10/31/202211,540,000 shares $142.06 million -2.1%37.6%18.3 $12.31 10/15/202211,790,000 shares $138.89 million -3.8%38.5%18.6 $11.78 9/30/202212,260,000 shares $145.89 million -6.6%40.0%18.6 $11.90 9/15/202213,130,000 shares $173.97 million +0.4%42.8%16.2 $13.25 8/31/202213,080,000 shares $182.07 million -3.0%42.6%13.8 $13.92 8/15/202213,490,000 shares $228.52 million -1.8%43.9%9.1 $16.94 7/31/202213,730,000 shares $205.26 million -4.3%45.1%8.7 $14.95 7/15/202214,340,000 shares $229.01 million +5.0%49.8%8.7 $15.97 6/30/202213,660,000 shares $194.66 million +12.8%47.4%8 $14.25 6/15/202212,110,000 shares $119.40 million -1.2%42.0%7.3 $9.86 5/31/202212,260,000 shares $144.18 million +6.4%42.6%8.5 $11.76 5/15/202211,520,000 shares $150.80 million +20.1%40.1%12.5 $13.09 4/30/20229,590,000 shares $138.96 million +23.3%32.7%10.4 $14.49 4/15/20227,780,000 shares $148.13 million -2.5%28.6%9.7 $19.04 3/31/20227,980,000 shares $166.14 million -3.3%29.4%10.1 $20.82 3/15/20228,250,000 shares $140.75 million +7.3%30.9%11.7 $17.06 2/28/20227,690,000 shares $121.81 million +11.0%28.8%11 $15.84 2/15/20226,930,000 shares $118.36 million +26.2%26.0%9.9 $17.08 1/31/20225,490,000 shares $88.17 million +13.9%20.1%9.9 $16.06 1/15/20224,820,000 shares $84.83 million +30.3%17.5%9.5 $17.60 12/31/20213,700,000 shares $85.47 million +18.2%13.4%8.6 $23.10 12/15/20213,130,000 shares $73.43 million +16.8%11.3%7.7 $23.46 11/30/20212,680,000 shares $58.29 million -0.7%9.7%6.9 $21.75 11/15/20212,700,000 shares $64.23 million -6.3%9.8%7.5 $23.79 10/29/20212,880,000 shares $68.03 million -1.7%10.5%7.7 $23.62 10/15/20212,930,000 shares $70.23 million -2.7%10.9%7.7 $23.97 9/30/20213,010,000 shares $89.70 million +30.3%11.2%7.7 $29.80 9/15/20212,310,000 shares $64.75 million -18.4%8.6%5.5 $28.03 8/31/20212,830,000 shares $85.89 million -1.4%10.6%7.2 $30.35 8/13/20212,870,000 shares $98.24 million -3.0%10.9%7.7 $34.23 7/30/20212,960,000 shares $100.67 million -3.3%11.4%8.3 $34.01 7/15/20213,060,000 shares $99.24 million -6.1%9.2%9.8 $32.43 6/30/20213,260,000 shares $111.36 million -1.5%9.9%11.7 $34.16 6/15/20213,310,000 shares $114.10 million -3.5%10.1%12.7 $34.47 5/28/20213,430,000 shares $117.99 million +4.6%10.5%15.1 $34.40 5/14/20213,280,000 shares $95.22 million -3.5%10.0%16 $29.03 4/30/20213,400,000 shares $115.91 million +3.0%10.6%19.3 $34.09 4/15/20213,300,000 shares $108.93 million +17.9%10.3%20.2 $33.01 3/31/20212,800,000 shares $86.86 million +54.7%8.8%18 $31.02 3/15/20211,810,000 shares $73.52 million +3.4%5.9%10.4 $40.62 2/26/20211,750,000 shares $63.33 million +7.4%5.7%11.5 $36.193 Dirt-Cheap Stocks You Can’t Afford to Ignore (Ad)Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.Get your FREE look at these THREE companies right here. 2/12/20211,630,000 shares $65.35 million +3.2%5.3%10 $40.09 1/29/20211,580,000 shares $55.28 million -11.2%5.2%9.2 $34.99 1/15/20211,780,000 shares $78.89 million No Change5.8%10.3 $44.32 PMVP Short Interest - Frequently Asked Questions What is PMV Pharmaceuticals' current short interest? Short interest is the volume of PMV Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 846,900 shares of PMVP short. 1.94% of PMV Pharmaceuticals' shares are currently sold short. Learn More on PMV Pharmaceuticals' current short interest. What is a good short interest ratio for PMV Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PMVP shares currently have a short interest ratio of 4.0. Learn More on PMV Pharmaceuticals's short interest ratio. What is a good short interest percentage for PMV Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.94% of PMV Pharmaceuticals' floating shares are currently sold short. Is PMV Pharmaceuticals' short interest increasing or decreasing? PMV Pharmaceuticals saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 846,900 shares, a drop of 0.0% from the previous total of 847,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is PMV Pharmaceuticals' float size? PMV Pharmaceuticals currently has issued a total of 51,750,000 shares. Some of PMV Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. PMV Pharmaceuticals currently has a public float of 43,730,000 shares. How does PMV Pharmaceuticals' short interest compare to its competitors? 1.94% of PMV Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to PMV Pharmaceuticals: Design Therapeutics, Inc. (8.56%), Kamada Ltd. (0.09%), Fate Therapeutics, Inc. (9.12%), Q32 Bio Inc. (13.71%), SNDL Inc. (1.89%), Eton Pharmaceuticals, Inc. (0.84%), Valneva SE (0.02%), AC Immune SA (1.70%), iTeos Therapeutics, Inc. (7.17%), C4 Therapeutics, Inc. (10.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short PMV Pharmaceuticals stock? Short selling PMVP is an investing strategy that aims to generate trading profit from PMV Pharmaceuticals as its price is falling. PMVP shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PMV Pharmaceuticals? A short squeeze for PMV Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PMVP, which in turn drives the price of the stock up even further. How often is PMV Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PMVP, twice per month. The most recent reporting period available is November, 15 2024. More Short Interest Resources from MarketBeat Related Companies DSGN Short Interest Data KMDA Short Interest Data FATE Short Interest Data QTTB Short Interest Data SNDL Short Interest Data ETON Short Interest Data VALN Short Interest Data ACIU Short Interest Data ITOS Short Interest Data CCCC Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PMVP) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMV Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PMV Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
